Department of Obstetrics & Gynecology, Oregon Health & Science University, Portland, OR, USA.
J Matern Fetal Neonatal Med. 2022 Oct;35(19):3684-3693. doi: 10.1080/14767058.2020.1837770. Epub 2020 Oct 25.
The primary concern for a trial of labor after cesarean (TOLAC) is a uterine rupture leading to neonatal injury or mortality and maternal mortality. In individuals who have a term stillbirth, the neonatal concern is absent, yet repeat cesarean delivery remains common in this setting. Given the increased maternal risks from cesarean, it is important to evaluate obstetric management options in the population of women who have a term stillbirth and prior cesarean delivery (CD).
To examine the outcomes and costs of a TOLAC induction of labor verses a repeat CD for cases of stillbirth occurring near term.
A decision-analytic model incorporating the current and a subsequent delivery using TreeAge software was designed to compare outcomes in women induced for a TOLAC to those undergoing repeat CD in the setting of stillbirth at 34-41 weeks' gestation. We used a theoretical cohort of 6000 women, the estimated annual number of women a prior cesarean who experience a stillbirth in the United States. Outcomes included quality-adjusted life years (QALY) for both modes of delivery with consideration of future pregnancy risks. Future pregnancy risks included uterine rupture, hysterectomy, placenta accreta, maternal death, neonatal death, and neonatal neurological deficits. Probabilities were derived from the literature, and a cost-effectiveness threshold was set at $100,000/QALY.
In our theoretical cohort of 6000 women with a prior CD and current stillbirth, induction of labor resulted in 4836 fewer cesarean deliveries during stillbirth management, 1040 fewer cesarean deliveries in the subsequent pregnancy, and 14 fewer cases of placenta accreta in the subsequent pregnancy, despite 29 additional uterine ruptures across both pregnancies. Induction of labor was found to be the dominant strategy, resulting in decreased costs and increased QALYs. Univariate sensitivity analyses demonstrated that induction of labor was cost effective until the risk of uterine rupture in the first delivery exceeded 0.83% (baseline estimate: 0.38%). Additional univariate sensitivity analyses found that induction of labor was cost effective until the risk of IOL failure in the first delivery exceeded 64% (baseline estimate: 19%).
In our theoretical cohort, induction of labor for TOLAC in the setting of a stillbirth with a history of prior CD is cost effective compared to a repeat CD. The results of this analysis demonstrate the benefit of induction of labor among women in this scenario who desire a future pregnancy.
剖宫产后试产(TOLAC)的主要关注点是子宫破裂导致新生儿受伤或死亡以及产妇死亡。在患有足月死产的个体中,新生儿的担忧不存在,但在这种情况下,再次剖宫产仍然很常见。鉴于剖宫产会增加产妇的风险,因此评估患有足月死产和先前剖宫产(CD)的女性人群的产科管理选择非常重要。
检查在接近足月时发生死产的情况下,TOLAC 引产与再次剖宫产的结局和成本。
使用 TreeAge 软件设计了一个纳入当前和后续分娩的决策分析模型,以比较在 34-41 周妊娠时因死产而接受 TOLAC 引产的女性与再次剖宫产的女性的结局。我们使用了一个理论队列的 6000 名女性,这是美国每年因先前剖宫产而经历死产的女性数量。结局包括两种分娩方式的质量调整生命年(QALY),同时考虑了未来妊娠风险。未来妊娠风险包括子宫破裂、子宫切除术、胎盘植入、产妇死亡、新生儿死亡和新生儿神经缺陷。概率来自文献,将成本效益阈值设定为 100000 美元/QALY。
在我们的 6000 名先前有 CD 且目前有死产的理论队列中,在死产管理期间,引产导致 4836 次剖宫产减少,后续妊娠中 1040 次剖宫产减少,后续妊娠中 14 次胎盘植入减少,尽管两次妊娠中增加了 29 例子宫破裂。引产被发现是一种更优的策略,降低了成本并增加了 QALYs。单变量敏感性分析表明,在第一次分娩的子宫破裂风险超过 0.83%(基线估计值:0.38%)之前,引产具有成本效益。进一步的单变量敏感性分析发现,在第一次分娩中诱导分娩失败的风险超过 64%(基线估计值:19%)之前,引产具有成本效益。
在我们的理论队列中,在有先前 CD 病史的死产情况下,TOLAC 引产与再次剖宫产相比具有成本效益。这项分析的结果表明,对于那些希望未来怀孕的此类情况下的女性,引产具有益处。